Radiolabeling of bombesin-like peptide with 99mTc: 99mTc-Litorin and biodistribution in rats

被引:15
作者
Durkan, Kubra [1 ]
Lambrecht, Fatma Yurt [1 ]
Unak, Perihan [1 ]
机构
[1] Ege Univ, Inst Sci Nucl, Dept Nucl Applicat, Izmir, Turkey
关键词
D O I
10.1021/bc060400x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bombesin-like peptides are related to several human cancer receptors, including small cell lung, prostate, breast, colon, and pancreatic cancers. Litorin, an amphibian bombesin peptide derivative, is found to stimulate the contraction of smooth muscle, to stimulate gastrin, gastric acid, and pancreatic secretion, and to suppress the nutriment in in vivo experiments. In the present study, litorin was labeled with 99mTc by the stannous chloride procedure. Labeling yield is 95 +/- 1.4%, as determined by radio thin layer chromatography (RTLC) and radio high performance chromatography (RHPLC). Results of in vitro studies demonstrated a high stability in serum and cysteine solutions. In vivo biodistribution was investigated with normal male Albino Wistar rats. Biodistribution data showed fast clearance, low intestinal accumulation, and significant uptake in bombesin/gastrin releasing peptide (BN/GRP) receptor rich tissues such as the pancreas (23.56 +/- 0.01 %ID/g 30 min pi). It can be blocked partially by previous administration of 'cold' litorin. The results showed specificity of the uptake. As Tc-99m-litorin displays good radiolabeling and biodistribution, it is a potentially useful radiopharmaceutical for detection of bombesin receptor-expressing cancers.
引用
收藏
页码:1516 / 1520
页数:5
相关论文
共 25 条
[11]   Receptor targeting for tumor localisation and therapy with radiopeptides [J].
Heppeler, A ;
Froidevaux, S ;
Eberle, AN ;
Maecke, HR .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (09) :971-994
[12]   99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent [J].
Karra, SR ;
Schibli, R ;
Gali, H ;
Katti, KV ;
Hoffman, TJ ;
Higginbotham, C ;
Sieckman, GL ;
Volkert, WA .
BIOCONJUGATE CHEMISTRY, 1999, 10 (02) :254-260
[13]   A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent [J].
La Bella, R ;
Garcia-Garayoa, E ;
Bähler, M ;
Bläuenstein, P ;
Schibli, R ;
Conrath, P ;
Tourwé, D ;
Schubiger, PA .
BIOCONJUGATE CHEMISTRY, 2002, 13 (03) :599-604
[14]   In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors [J].
La Bella, R ;
Garcia-Garayoa, E ;
Langer, M ;
Bläuenstein, P ;
Beck-Sickinger, AG ;
Schubiger, PA .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (05) :553-560
[15]   A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier [J].
Lin, KS ;
Luu, A ;
Baidoo, KE ;
Hashemzadeh-Gargari, H ;
Chen, MK ;
Pili, R ;
Pomper, M ;
Carducci, M ;
Wagner, HN .
BIOCONJUGATE CHEMISTRY, 2004, 15 (06) :1416-1423
[16]  
MIHAEL JW, 2003, HDB RADIOPHARMACEUTI, P643
[17]   [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging [J].
Nock, B ;
Nikolopoulou, A ;
Chiotellis, E ;
Loudos, G ;
Maintas, D ;
Reubi, JC ;
Maina, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (02) :247-258
[18]   Development and function of bombesin-like peptides and their receptors [J].
Ohki-Hamazaki, H ;
Iwabuchi, M ;
Maekawa, F .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2005, 49 (2-3) :293-300
[19]   Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases [J].
Okarvi, SM .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (03) :357-397
[20]  
Okarvi SM, 2003, ANTICANCER RES, V23, P2745